Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
RPHM Reneo Pharmaceuticals
3.030-0.190-5.90%
Close
02/08 16:00 ET
3.0300.0000.00%
Post Mkt Price 02/08 16:00 ET
High
3.200
Open
3.170
Turnover
86.53K
Low
3.030
Pre Close
3.220
Volume
27.72K
Post-Market
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
Reneo Pharmaceuticals to Participate in SVB Securities Global Biopharma Conference
IRVINE, Calif., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM), a clinical stage pharmaceutical company focused on the development and commercialization of therapies for patients with rare,
Reneo Stock Rises on FDA Fast Track Status for Rare Metabolic Disorder Drug
Reneo Pharmaceuticals Receives Fast Track Designation From FDA for REN001
Reneo Pharmaceuticals Receives Fast Track Designation From FDA For Mavodelpar In A Genotype Af Long-Chain Fatty Acid Oxidation Disorder
Reneo Pharmaceuticals Receives Fast Track Designation From FDA For Mavodelpar In A Genotype Af Long-Chain Fatty Acid Oxidation Disorder
Jefferies Financial Group Comments on Reneo Pharmaceuticals, Inc.'s FY2027 Earnings (NASDAQ:RPHM)
Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM – Get Rating) – Research analysts at Jefferies Financial Group issued their FY2027 earnings per share (EPS) estimates for Reneo Pharmaceuticals in a researc
Reneo Pharmaceuticals (RPHM) Receives a Buy From Jefferies
Reneo Pharmaceuticals (NASDAQ:RPHM) Trading Up 2%
Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM – Get Rating)'s stock price was up 2% during trading on Tuesday . The stock traded as high as $2.64 and last traded at $2.55. Approximately 125,887 shares tra
Reneo Pharmaceuticals (NASDAQ:RPHM) Trading Up 4.8%
Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM – Get Rating) shares shot up 4.8% during mid-day trading on Monday . The stock traded as high as $2.21 and last traded at $2.19. 10 shares traded hands during
Reneo Pharmaceuticals Q3 EPS $(0.53) Down From $(0.52) YoY
Reneo Pharmaceuticals (NASDAQ:RPHM) reported quarterly losses of $(0.53) per share. This is a 1.92 percent decrease over losses of $(0.52) per share from the same period last year.
Reneo Pharmaceuticals 3Q Loss/Shr 53c >RPHM
Company Overview
More
Reneo Pharmaceuticals, Inc. is a clinical-stage company, which engages in the research and development of therapies for rare genetic mitochondrial diseases. The company was founded by Michael G. Grey and Niall O'Donnell on September 22, 2014 and is headquartered in San Diego, CA.
CEO： Mr. Gregory J. Flesher
Market： NASDAQ
Listing Date： 04/09/2021
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet